Mark Cuban Cost Plus Drug Co. recently expanded its network of independent pharmacies from 36 to 80 across seven states. 

Teva Pharmaceuticals will stop shipping 36 discounted drugs to contract pharmacies July 5 because of its concerns of a diluted 340B program, according to a letter acquired by 340B Health. 

Metformin — a first-line treatment for Type 2 diabetes — significantly lowers the risk of developing long COVID-19 when taken within the first few days of infection, according to new findings from researchers at the University of Minnesota Medical School in Minneapolis. 

The American Society of Health-System Pharmacists honored 41 members as 2023 Fellows for their "excellence in pharmacy practice," the organization said June 8. 

The ongoing shortages of numerous oncology medications are causing delays in care for patients at cancer centers, according to a study from the National Comprehensive Cancer Network. 

Seventy percent of the 20 most commonly prescribed medications from GoodRx are in shortage, according to databases from the FDA and the American Society of Health-System Pharmacists.

The Department of Defense is designing a program to assess the safety of widely used generic drugs amid concerns over their quality, Bloomberg reported June 7.

Atlanta-based Mercer University College of Pharmacy secured a deal with another Georgia university to promise priority applicant status for Mercer's PharmD program and cut one school year. 

Local anesthetics bupivacaine and lidocaine have been in unsteady supply since at least 2015, and recently, drugmakers postponed their expected resupply dates again. 

Shortages of a handful of cancer drugs are causing concern as drug companies delay resupply dates and physicians worry about providing adequate care for their patients. 

Mark Cuban Cost Plus Drug Co., a mail-order pharmacy with thousands of generics and a handful of brand-name drugs, has partnered with two mail-order pharmacies. 

AstraZeneca's approved lung cancer drug Tagrisso (osimertinib) reduced the risk of death by 51 percent in a phase 3 study that involved 682 patients with non-small cell lung cancer. 

As local pharmacies and hospitals struggle to staff teams with enough pharmacy technicians, Kavish Choudhary, PharmD, chief pharmacy officer of University of Utah Health, told Becker's five pieces of advice.

As drugmakers continue to delay resupply dates for cisplatin, a cancer drug in a monthslong shortage, the FDA allowed a China-based pharmaceutical company to temporarily import some solutions. 

Mark Cuban Cost Plus Drug Co. will raise its pharmacy labor fee from $3 to $5, effective Sept. 1.

A phase 3 trial of pharmaceutical giant Pfizer's newly developed antibiotic combination revealed positive results, revealing a promising treatment for superbug infections, according to a June 1 press release.

The National Institutes of Health's cancer unit is launching the largest study to test combinations of cancer drugs in comparison to the drugs on their own, the organization said June 1. 

After CMS announced plans to preserve availability of Alzheimer's drugs, the Alzheimer's Association has issued a statement in opposition of it.

University of Florida Health's specialty pharmacy recently expanded its list of medications and accepted insurance plans. 

As the U.S. experiences the highest number of drug shortages in 10 years, the FDA and the American Society of Health-System Pharmacists reported 17 new shortages in May.